Dr. Paulisally Lo, Senior Scientist is with Rohto Advanced Research Hong Kong Limited (RARHK), a subsidiary company from Rohto Pharmaceutical Co., Ltd. Her research focuses on identifying the mechanism of action of cell therapy by allogenic mesenchymal stem cells (MSCs). She received her Ph.D. degree at the Department of Clinical Oncology, The University of Hong Kong followed by her post-doctoral training at The University of Tokyo under the supervision by Prof. Yusuke Nakamura.

Paulisally has joined RARHK in 2020 starting with establishment of different in-vitro assays on testing the effects of MSCs. She aims to establish and provide disease specific models for assessing the regenerative ability of MSCs as well as MSC derived biologics.